Effect of Lipid Levels and Lipid-Lowering Therapy on Restenosis after Coronary Artery Stenting-Reference-Cited by-同舟云学术

Effect of Lipid Levels and Lipid-Lowering Therapy on Restenosis after Coronary Artery Stenting

Published:2006-05 Issue:5 Volume:331 Page:270-273
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Lerakis Stamatios,El-Chami Mikhael F.,Patel Amar D.,Veledar Emir,Alexopoulos Elias,Zacharoulis Achilleas,Triantafyllou Aggeliki

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study;Scandinavian Simvastatin Survival Study Group;Lancet,1994

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels;Sacks;N Engl J Med,1996

3. Prevention of cardiovascular events and death with pravastatin in patients with coronary disease and a broad range of initial cholesterol levels;The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study group;N Engl J Med,1998

4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomized placebo-controlled trial;Heart Protection Study Collaborative Group;Lancet,2002

5. Early statin treatment following acute myocardial infacrtion and 1-year survival;Stenestrand;JAMA,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide;Atherosclerosis;2024-03

2. Hypercholesterolemia aggravates in-stent restenosis in rabbits: a mitigating effect of stent surface modification with CD47-derived peptide;2023-02-28

3. An overview of in-stent restenosis in iliofemoral venous stents;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2021-11

4. Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study;BMC Cardiovascular Disorders;2014-10-10

5. Risk Factors for Cardiovascular Events in Japanese Patients Treated with Fluvastatin from the Long-Term Event Monitoring (LEM) Study;Current Vascular Pharmacology;2012-03-01